Growth of tumor-infiltrating lymphocytes from human solid cancers: Summary of a 5-year experience

International Journal of Cancer

Volumn 65, Issue 4, 1996, Pages 413-421

  Yannelli, John R ^a,b   Hyatt, Cornelia ^a   McConnell, Susan ^a   Hines, Ken ^a   Jacknin, Laura ^a   Parker, Linda ^a   Sanders, Melinda ^a   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ARTICLE; BREAST CANCER; CELL GROWTH; COLON CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MALE; MELANOMA; PRIORITY JOURNAL; SOLID TUMOR; TUMOR ASSOCIATED LEUKOCYTE; TUMOR BIOPSY;

EID: 0029882491     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19960208)65:4<413::aid-ijc3>3.0.co;2-#     Document Type: Article

References (45)

1. AEBERSOLD, P., HYATT, C., JOHNSON, S., HINES, K., KORCAK, L., SENDERS, M., LOTZE, M., TOPALIAN, S., YANG, J. and ROSENBERG, S.A., Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J. nat. Cancer Inst., 83, 932-937 (1991).
2. AOKI, Y., TAKAKUWA, K., KODAMA, S., TANAKA, S., TAKAHASHI, M., TOKUNAGA, A. and TAKAHASHI, T., Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin containing chemotherapy in patients with epithelial ovarian cancer. Cancer Res., 51, 1934-1939 (1991).
3. ARIENTI, F., BELLI, F., RIVOLTLNI, L., GAMBACORTI-PASSERINI, C., FURLIN, L., MASCHERONI, L., PRADA, A., RIZZI, M., MARCHESI, E., VAGLINI, M., PARMIANI, G. and CASCINELLI, N., Advanced immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor infiltrating lymphocytes selected in vitro with low doses of IL-2. Cancer Immunol. Immunother., 36, 315-322 (1993)
4. BELLDEGRUN, A., MUUL, L.M. and ROSENBERG, S.A., Interleukin 2 expanded tumor infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and anti-tumor activity. Cancer Res., 48, 206-214 (1988).
5. BELLDEGRLN, A., PIERCE, W., KABOO, R., TSO, C.L., SHAW, H., TUZCILLO, P., MOLDAMER, N., GOLUB, S., DE KEZNION, J. and FIGLIU, R., Interferon-alpha primed tumor infiltrating lymphocytes combined with interleukin-2 and interpheron-alpha as therapy for metastatic renal cell carcinoma. J. Urol., 150, 1384-1390 (1993).
6. + melanoma. J. exp. Med., 178, 489-495 (1993).
7. BUKOWSKI, R.M., SHARFMAN, W., MURTHY, S., RAYMAN, P., TUBBS, R., ALEXANDER, J., BUDD, G.T., SERGI, J., BAUER, L., GIBSON, V., STANLEY, J., BUYERT, J., PONTES, E. and FINKE, J., Clinical results and characterization of tumor infiltrating lymphocytes with and without interleukin-2 in human metastatic renal cell carcinoma. Cancer Res., 51, 4199-4205 (1991).
8. COULIE, P.G., BRICHARD, V., VAN PEL, A., WOLFEL, T., SCHNEIDER, J., TRAVERSARI, C., MATTEI S., DE PLAEN, E., LURQUIN, C., SZIKORA, J.P., RENAULT, J.P. and BOONE, T., A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. exp. Med., 180, 35-42 (1994).
9. DILLMAN, R.O., OLDHAM, R.K., BARTH, N.M., COHEN, R.J., MINOR, D.R., BIRCH, R., YANNELLI, J.R., MALECKAR, J.R., SFERRUZZA, A., ARNOLD, A. and WEST, W.H., Continuous interleukin-2 and tumor infiltrating lymphocytes as treatment of advanced melanoma. A National Biotherapy Study Group trial. Cancer, 68, 1-14 (1991).
10. FISHER, B., PACKARD, B.S., READ, E.J., CARRASOUILLO, J.A., CARTER, C.S., TOPALIAN, S.L., YANG, J.C., YOLLES, P., LARSOU, S.M. and ROSENBERG, S.A., Tumor localization of adoptively transferred indium-111 labelled tumor infiltrating lymphocytes in patients with metastatic melanoma. J. clin. Oncol. 7, 250-260 (1989).
11. FREEDMAN, R.S., EDWARDS, C.L., KAVANAGH, J.J., KUDELKA, A.P., KATZ, R.L., CARRASCO, C.H., ATKINSON, E.N., SCOTT, W., TOMASOVIC, B., TEMPLIN, S. and PLATSOLUCAS, C.D., Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot study. J. Immunother., 16, 198-210 (1994).
12. GRIFFITH, K.D., READ, E.J., CARASOUILLO, J.A., CARTER, C.S., YANG, J.C., FISHER, B., AEBERSOLD, P., PACKARD, B.S., YU, M.S. and ROSENBERG, S.A., In vivo distribution of adoptively transferred indium-111 labelled tumor infiltrating lymphocytes and peripheral blood lympbocytes in patients with metastatic melanoma. J. nat. Cancer Inst., 81, 1709-1717 (1989).
13. HAAS, O.P., SOLOMON, D., and ROSENBERG, S.A., Tumor infiltrating lymphocytes from nonrenal urological malignancies. Cancer Immunol. Immunother., 30, 342-350 (1990).
14. HEO, D.S., WHITESIDE, T.L., JOHNSON, J.T., CHEN, K., BARNES, E.L. and HERBERMAM, R.B., Long term interleukin-2 dependent growth and cytotoxic activity of tumor infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. Cancer Res., 47, 6353-6362 (1987).
15. HOM, S.S., ROSENBERG, S.A. and TOPALIAN, S.L., Specific immune recognition of autologous tumor by lymphocytes infiltrating colon carcinomas: analysis by cytokine secretion. Cancer Immunol. Immunother, 36, 1-8 (1993a).
16. HOM, S.S., SCHWARTZENTRUBER, D.J., ROSENBERG, S.A., and TOPALIAN, S.L., Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma tumor antigens. J Immunother., 13, 18-30 (1993b).
17. HOM, S.S., TOPALIAN, S.L., SIMONIS, T., MANCINI, M. and ROSENBERG, S.A., Common expression of melanoma tumor-associated antigens recognized by human tumor infiltrating lymphocytes: analysis by human lymphocyte antigen restriction. J. Immunother., 10, 153-164 (1991).
18. ITOH, K., TILDEN, A.B. and BALCH, C.M., Interleukin-2 activation of cytotoxic T lymphocytes infiltrating into human metastatic melanomas. Cancer Res., 46, 3011-3017 (1986).
19. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.P., RIVOLTINI, L., TOPALIAN, S.L., MIKI, T and ROSENBERG, S.A., Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. nat. Acad. Sci. (Wash.), 91, 3515-3519 (1994a).
20. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.P., SAKAGLCHI, K., APPELLA, E., YANNELLI, J.R., ADAMA, G.J., MIKI, T. and ROSENBERG, S.A., Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc. nat Acad. Sci. (Wash.), 91, 6458-6462 (1994b).
21. KAWAKAMI, Y., ELIYAHU, S., SAKAGUCHI, K., ROBBINS, P.P., RIVOLTINI, L., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Identification of the immunodominant peptides of MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. exp Med., 180, 347-352 (1994c).
22. KNAZEK, R.A., WU, Y.W., AEBERSOLD, P.A. and ROSENBERG, S.A., Culture of tumor infiltrating lymphocytes in hollow fiber bioreactors. J Immunol. Meth., 127, 29-37 (1990).
23. KRADIN, R.L., BOYLE, L.A., PREFFER, F.I., CALLAHAN, R.J., BARLAIKOYACH, M., STRALSS, H.W., DUBINETT, S. and JURNICK, J.T., Tumor derived interleukin-2 dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol. Immunother., 24, 76-85 (1987).
24. KRADIN, R.L., KURNICK, J.T., LAZARUS, D.S., PREFER, F.I., DUBINETT, S.M., PINTO, C E., GIFFORD, J., DAVIDSON, E., GROVE, B., CALLAHAN, R.J. and STRAUSS, H.W., Tumor infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet. 1, 577-580 (1989).
25. MALECKAR, J.R., FRIDDELL, C.S., SFERRUZZA, A., THURMAN, G.B., LEWKO, W.M., WEST, W.H., OLDHAM, R.K. and YANNELLI, J.R., Activation and expansion of tumor derived activated cells for therapeutic use. J. nat. Cancer Inst., 81, 1055-1660 (1989).
26. MUUL, L.M., NASON-BURCHENAL, K., CARTER, C.S., CULLIS, H., SLAVIN, D., HYATT, C., DIRECTOR, E., LEITMAN, S.F., KLEIN, H.G. and ROSENBERG, S.A., Development of an automated closed system for generation of human lymphokine activated killer cells (LAK) for use in adoptive immunotherapy. J. Immunol. Meth., 101, 171-182 (1987a).
27. MUUL, L.M., SPIESS, P.J., DIRECTOR, E.P. and ROSENBERG, S.A., Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol., 138, 989-995 (1987b).
28. OLIVER, G., YANNELLI, J.R. and SOLOMON, D., Tumor infiltrating lymphocytes: a cytologic, phenotypic. and morphometric analysis. Acta cytol. (1996). (In press).
29. 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Cancer, 73, 1731-1737 (1994).
30. RIVOLTINI, L., KAWAKAMI, Y., SAKAGUCHI, K., SOUTHWOOD, S., SETTE, A., ROBBINS, P.F., MARINCOLA, F., SALGALLER, M., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Induction of tumor reactive CTL from peripheral blood and tumor infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154, 2257-2265 (1995).
31. ROBBINS, P.F., EL-GAMIL, M., KAWAKAMI, Y., STEVENS, E.M., YANNELLI, J.R. and ROSENBERG, S.A., Recognition of tyrosinase by tumor infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res., 54, 3124-3126 (1994).
32. ROSENBERG, S.A. and 14 OTHERS, Gene transfer into humans - immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. New Engl. J. Med., 323, 570-578 (1990).
33. ROSENBERG, S.A. and 15 OTHERS, Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. New Engl. J. Med., 319, 1676-1680 (1988).
34. ROSENBERG, S.A., SPEISS, P. and LAFRENIERE, R., A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science, 233, 1318-1321 (1986).
35. ROSENBERG, S.A., YANNELLI, J.R., YANG, J.C., TOPALIAN, S.L., SCHWARTZENTRUBER, D.J., WEBER, J.S., PARKINSON, D.R., SEIPP, C.A., EINHORN, J.H. and WHITE, D.E., Treatment of patients with metastatic melanoma with autologous tumor infiltrating lymphocytes and interleukin-2. J nat. Cancer Inst., 86, 1159-1166 (1994).
36. SCHENDEL, D.J. and GANSBACHER, B., Tumor specific lysis of human renal cell carcinomas by tumor infiltrating lymphocytes: modulation of recognition through retrovirus transduction of tumor-cells with interleukin-2 complementary DNA and exogenous alpha Interferon treatment. Cancer Res., 53, 4020-4025 (1993).
37. SCHWARTZENTRUBER, D.L., HOM, S.S., UADMARZ, R., WHITE, D.E., YANNELLI, J.R., STEINBERG, S.M., ROSENBERG, S.A. and TOPALIAN, S.L., In vitro predictors of therapeutic response in melanoma patients receiving tumor infiltrating lymphocytes and interleukin-2. J. clin. Oncol., 12, 1475-1483 (1994).
38. SCHWARTZENTRUBER, D.J., SOLOMON, D., ROSENBERG, S.A. and TOPALIAN, S.L., Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. J. Immunother., 12, 1-12 (1992).
39. STEVENS, E.J., JACKNIN, L., ROBBINS, P.P., KAWAKAMI, Y., EL-GAMIL, M., ROSENBERG, S.A. and YANNELLI, J.R., Generation of tumor specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines: fine specificity and MART-1 melanoma antigen recognition. J. Immunol, 154, 762-771 (1995).
40. TOPALIAN, S.L., MUUL, L.M., SOLOMON, D. and ROSENBERG, S.A., Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Meth., 102, 127-141 (1987).
41. TOPALIAN, S.L., SOLOMON, D., AVIS, P.P., CHANG, A.E., FREERKSON, D.L., LINEHAN, W.M., LOTZE, M.T., ROBERTSON, C.N., SEIPP, C.A., SIMON, P., SIMPSON, C. and ROSENBERG, S.A., Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J. clin. Oncol., 6, 839-853 (1988).
42. TOPALIAN, S.L., SOLOMON, D. and ROSENBERG, S.A., Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J. Immunol., 142, 3714-3732 (1989).
43. WANG, R.F., ROBBINS, P.P., KAWAKAMI, Y., KANG, X.Q. and ROSENBERG, S.A., Identification of a gene encoding a melanoma antigen recognized by HLA-A31 restricted tumor infiltrating lymphocytes. J. exp. Med., 181, 799-504 (1995).
44. YANNELLI, J.R., HYATT, C., JOHNSON, S., Hwu, P. and ROSENBERG, S.A., Characterization of human tumor cell lines transduced with the cDNA encoding either tumor necrosis factor alpha (TNF-alpha) or interleukin-2 (IL-2). J. Immunol. Meth., 161, 77-90 (1993).
45. YOO, Y.K., HEO, D.S., HATA, K., VAN THIEL, D.H. and WHITESIDE, T.L., Tumor-infiltrating lymphocytes from human colon carcinomas. Gastroenterology, 98, 259-268 (1990).